Abstract
Background: Sanguinarine, a benzophenanthridine alkaloid extracted from Sanguinaria canadensis has been found to show an inhibitory role on proapoptotic and growth inhibitory activities in various tumor cells of experimental subjects.
Objective: This review highlights and summarizes the effects of sanguinarine against cancers alongside the possible mechanisms involved as depicted in various in vitro and in vivo models.
Results: Sanguinarine shows anticancer activities via various mechanisms like inhibiting cancer cell proliferation, aberrantly activated signal transduction pathways, sang-mediated angiogenesis, and induction of cell death and tumor suppressors’ expressions. It also enhances the cytotoxic effects of chemotherapeutics via sensitizing cancer cells against these drugs, hence improving their pharmacological attributes.
Conclusion: Due to the significant role of sanguinarine against various types of cancer, it can be explored for its potential functions in cancer treatment.
Keywords: Sanguinarine, phytochemical, anticancer agent, human cancer, tumor cells, cytotoxic.
Graphical Abstract
Related Journals
Anti-Cancer Agents in Medicinal Chemistry
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
Current Drug Safety
Current Drug Targets
Current Organic Chemistry
Current Organic Synthesis
Mini-Reviews in Organic Chemistry
Letters in Organic Chemistry
Letters in Drug Design & Discovery
Current Drug Discovery Technologies
Related Books
Advances in Organic Synthesis
Frontiers in Drug Design and Discovery
The Synthetic Methods, Structures, and Properties of the Ca-C σ Bond Organocalcium Containing Compounds
Advances in Organic Synthesis
Chemistry of Bipyrazoles: Synthesis and Applications
Frontiers in Cardiovascular Drug Discovery
Advances in Organic Synthesis
Advanced Nanocatalysis for Organic Synthesis and Electroanalysis
Frontiers in Drug Design and Discovery
Advances in Organic Synthesis
6